Please use this identifier to cite or link to this item:
https://dspace.iiti.ac.in/handle/123456789/3860
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jakhmola, Shweta | en_US |
dc.contributor.author | Baral, Budhadev | en_US |
dc.contributor.author | Jha, Hem Chandra | en_US |
dc.date.accessioned | 2022-03-17T01:00:00Z | - |
dc.date.accessioned | 2022-03-17T15:30:51Z | - |
dc.date.available | 2022-03-17T01:00:00Z | - |
dc.date.available | 2022-03-17T15:30:51Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Jakhmola, S., Baral, B., Muduli, K., Suar, M., Das, P., Patnaik, P. K., . . . Jha, H. C. (2021). The interrelation of COVID-19 and neurological modalities. Neurological Sciences, 42(6), 2157-2160. doi:10.1007/s10072-021-05177-3 | en_US |
dc.identifier.issn | 1590-1874 | - |
dc.identifier.other | EID(2-s2.0-85102612375) | - |
dc.identifier.uri | https://doi.org/10.1007/s10072-021-05177-3 | - |
dc.identifier.uri | https://dspace.iiti.ac.in/handle/123456789/3860 | - |
dc.description.abstract | [No abstract available] | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer-Verlag Italia s.r.l. | en_US |
dc.source | Neurological Sciences | en_US |
dc.subject | C reactive protein | en_US |
dc.subject | D dimer | en_US |
dc.subject | lactate dehydrogenase | en_US |
dc.subject | procalcitonin | en_US |
dc.subject | adult | en_US |
dc.subject | aged | en_US |
dc.subject | clinical article | en_US |
dc.subject | clinical outcome | en_US |
dc.subject | comorbidity | en_US |
dc.subject | coronavirus disease 2019 | en_US |
dc.subject | cytokine storm | en_US |
dc.subject | disease association | en_US |
dc.subject | hospital admission | en_US |
dc.subject | hospitalization | en_US |
dc.subject | human | en_US |
dc.subject | intensive care unit | en_US |
dc.subject | Letter | en_US |
dc.subject | leukocyte count | en_US |
dc.subject | lymphocyte | en_US |
dc.subject | lymphocyte count | en_US |
dc.subject | male | en_US |
dc.subject | meningoencephalitis | en_US |
dc.subject | middle aged | en_US |
dc.subject | mortality | en_US |
dc.subject | nervous system inflammation | en_US |
dc.subject | neurological complication | en_US |
dc.subject | neutrophil | en_US |
dc.subject | neutrophil count | en_US |
dc.subject | pathology | en_US |
dc.subject | platelet count | en_US |
dc.subject | protein blood level | en_US |
dc.subject | Severe acute respiratory syndrome coronavirus 2 | en_US |
dc.subject | neurologic disease | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | Humans | en_US |
dc.subject | Nervous System Diseases | en_US |
dc.subject | SARS-CoV-2 | en_US |
dc.title | The interrelation of COVID-19 and neurological modalities | en_US |
dc.type | Letter | en_US |
dc.rights.license | All Open Access, Bronze, Green | - |
Appears in Collections: | Department of Biosciences and Biomedical Engineering |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Altmetric Badge: